Results 171 to 180 of about 53,790 (237)

Complement C5a Measurement [PDF]

, 2020
openaire   +1 more source

tRF3a-MetCAT Promotes EGFR-Targeted Therapeutic Resistance through the TRIM21-STAT1-C5a Axis in Lung Adenocarcinoma. [PDF]

Research (Wash D C)
Zhang Y, Zhou P, Guo Y, Zhang H, Gu J, Ge D, Zhao G.   +6 more
europepmc   +1 more source

Progress in the study of the role of C5a-induced tubular cell senescence in the progression of diabetic kidney disease. [PDF]

Ann Med
Guo C, Li X, Fan Z, Zhang J, Chen M.
europepmc   +1 more source

Role of Complement Anaphylatoxins (C3a and C5a) in Lymphoma: A Systematic Review. [PDF]

Cureus
Skarentzos K, Vryttia P, Papageorgiou S, Foukas P.   +3 more
europepmc   +1 more source

Feasibility study of very high aprotinin dosage in polytrauma patients [PDF]

, 1987
Clasen, C., Jochum, Marianne, Müller-Esterl, Werner, Redl, H., Schlag, G.   +4 more
core  

Functional and Structural Characterization of Treatment-Emergent Nirmatrelvir Resistance Mutations at Low Frequencies in the Main Protease (Mpro) Reveals a Unique Evolutionary Route for SARS-CoV-2 to Gain Resistance. [PDF]

J Infect Dis
Deschenes NM, Pérez-Vargas J, Zhong Z, Thomas M, Kenward C, Mosimann WA, Worrall LJ, Waglechner N, Li AX, Maguire F, Aftanas P, Smith JR, Lim J, Young RN, Cherkasov A, Farooqi L, Moinuddin A, Siddiqi L, Malik I, Lefebvre M, Paetzel M, Strynadka NCJ, Jean F, McGeer A, Kozak RA.   +24 more
europepmc   +1 more source

Complement 5a (C5a) [PDF]

Science-Business eXchange, 2010
openaire   +1 more source

Redox Regulation of Complement Pathway Activation in Aging and Related Diseases. [PDF]

Antioxidants (Basel)
Ferdowsi S, Arjuna S, Sj S, Zennadi R.
europepmc   +1 more source

The free fatty acid 2 receptor regulates the activation potency of C5a and the sensitivity to the antagonist avacopan

Khan Z, Levin NK, Dahlgren C, Sundqvist M, Khan F, Forsman H, Björkman L.   +6 more
europepmc   +1 more source

Correction: Neutrophils as key drivers of pulmonary fibrosis: unveiling mechanisms and therapeutic implications. [PDF]

Front Immunol
Liang X, Li Y, Tang Z, Luo Y, Liu Y.
europepmc   +1 more source